Company profile: Baseclick
1.1 - Company Overview
Company description
- Provider of click chemistry reagents (clickable dyes, tags, sugars, amino acids), custom DNA/RNA/LNA oligonucleotide synthesis, mRNA synthesis and modification, EdU cell proliferation assays, FISH and PCR kits, and click chemistry-based NGS solutions for full-length transcriptomics compatible with all sequencing devices; also offers licensing of proprietary click chemistry and DNA photography technologies and collaboration for further development.
Products and services
- Click Chemistry Reagents: Delivers research-grade clickable dyes, tags, sugars, and amino acids enabling precise biomolecule labeling and conjugation for diagnostics, therapeutics, and vaccine development
- Next Generation Sequencing (NGS) Solutions: Architects platform-agnostic, click chemistry-based products that obtain complete full-length transcript information from 5′ to 3′ in transcriptomics, compatible with all sequencing devices
- MRNA Service: Produces custom-engineered mRNA synthesis and modification for research and clinical applications, including drug development and vaccine discovery
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Baseclick
Integrated DNA Technologies
HQ: United States
Website
- Description: Provider of custom DNA and RNA oligonucleotides with various modifications; CRISPR-Cas9 reagents and tools for genome editing; gBlocks double-stranded gene fragments (125-3000 bp) for gene assembly, qPCR, and NGS; PrimeTime qPCR probes with dye and quencher options for multiplex gene expression analysis; and xGen DNA library prep kits for next-generation sequencing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Integrated DNA Technologies company profile →
IBA Lifesciences
HQ: Germany
Website
- Description: Provider of life science technologies including the Strep-tag system for high-purity, high-yield recombinant protein purification and analysis; Strep-Tactin XT for strong, reversible binding to Twin-Strep-tag peptides; MagStrep Strep-Tactin XT beads and Strep-Tactin XT 4Flow resins for efficient purification; the MEXi mammalian cell production system; and StrepMAB-Immo for SPR analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IBA Lifesciences company profile →
ExpreS2ion Biotechnologies
HQ: Denmark
Website
- Description: Provider of innovative vaccines and the human clinical Phase III-validated ExpreS2™ technology platform for fast and efficient development of novel, life-saving vaccines that improve quality of life worldwide.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ExpreS2ion Biotechnologies company profile →
IC Biotec
HQ: United States
Website
- Description: Provider of cloning and associated services to advance reproduction in mammalian species for domestic and international clients across academia and industry, supported by state-of-the-art facilities and a highly skilled scientific team.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IC Biotec company profile →
Multiplicom
HQ: Belgium
Website
- Description: Provider of molecular diagnostics products and clinical laboratory-based tests, including DNA/RNA library preparation and hybrid-capture target enrichment kits for Illumina sequencing. Offerings support low-input and FFPE samples, whole-genome and targeted sequencing, liquid biopsy applications, include molecular barcodes, and enable detection of low-frequency alleles.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Multiplicom company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Baseclick
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Baseclick
2.2 - Growth funds investing in similar companies to Baseclick
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Baseclick
4.2 - Public trading comparable groups for Baseclick
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →